                         SEQUENCE LISTING

<110>  ITH Immune Therapy Holdings AB
 
<120>  TREATING MULTIPLE SCLEROSIS

<130>  P117759WO00

<160>  31    

<170>  PatentIn version 3.5

<210>  1
<211>  99
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide

<400>  1

Met Lys Val Ser Ala Ala Leu Leu Cys Leu Leu Leu Ile Ala Ala Thr 
1               5                   10                  15      


Phe Ile Pro Gln Gly Leu Ala Gln Pro Asp Ala Ile Asn Ala Pro Val 
            20                  25                  30          


Thr Cys Cys Tyr Asn Phe Thr Asn Arg Lys Ile Ser Val Gln Arg Leu 
        35                  40                  45              


Ala Ser Tyr Arg Arg Ile Thr Ser Ser Lys Cys Pro Lys Glu Ala Val 
    50                  55                  60                  


Ile Phe Lys Thr Ile Val Ala Lys Glu Ile Cys Ala Asp Pro Lys Gln 
65                  70                  75                  80  


Lys Trp Val Gln Asp Ser Met Asp His Leu Asp Lys Gln Thr Gln Thr 
                85                  90                  95      


Pro Lys Thr 
            


<210>  2
<211>  76
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (64)..(64)
<223>  X = Met or Nleu

<400>  2

Gln Pro Asp Ala Ile Asn Ala Pro Val Thr Cys Cys Tyr Asn Phe Thr 
1               5                   10                  15      


Asn Arg Lys Ile Ser Val Gln Arg Leu Ala Ser Tyr Arg Arg Ile Thr 
            20                  25                  30          


Ser Ser Lys Cys Pro Lys Glu Ala Val Ile Phe Lys Thr Ile Val Ala 
        35                  40                  45              


Lys Glu Ile Cys Ala Asp Pro Lys Gln Lys Trp Val Gln Asp Ser Xaa 
    50                  55                  60                  


Asp His Leu Asp Lys Gln Thr Gln Thr Pro Lys Thr 
65                  70                  75      


<210>  3
<211>  68
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide

<400>  3

Val Thr Cys Cys Tyr Asn Phe Thr Asn Arg Lys Ile Ser Val Gln Arg 
1               5                   10                  15      


Leu Ala Ser Tyr Arg Arg Ile Thr Ser Ser Lys Cys Pro Lys Glu Ala 
            20                  25                  30          


Val Ile Phe Lys Thr Ile Val Ala Lys Glu Ile Cys Ala Asp Pro Lys 
        35                  40                  45              


Gln Lys Trp Val Gln Asp Ser Met Asp His Leu Asp Lys Gln Thr Gln 
    50                  55                  60                  


Thr Pro Lys Thr 
65              


<210>  4
<211>  104
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide

<400>  4

Met Lys Ile Ser Thr Leu Leu Cys Leu Leu Leu Ile Ala Thr Thr Ile 
1               5                   10                  15      


Ser Pro Gln Val Leu Ala Gly Pro Asp Ala Val Ser Thr Pro Val Thr 
            20                  25                  30          


Cys Cys Tyr Asn Val Val Lys Gln Lys Ile His Val Arg Lys Leu Lys 
        35                  40                  45              


Ser Tyr Arg Arg Ile Thr Ser Ser Gln Cys Pro Arg Glu Ala Val Ile 
    50                  55                  60                  


Phe Arg Thr Ile Leu Asp Lys Glu Ile Cys Ala Asp Pro Lys Glu Lys 
65                  70                  75                  80  


Trp Val Lys Asn Ser Ile Asn His Leu Asp Lys Thr Ser Gln Thr Phe 
                85                  90                  95      


Ile Leu Glu Pro Ser Cys Leu Gly 
            100                 


<210>  5
<211>  82
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide

<400>  5

Gly Pro Asp Ala Val Ser Thr Pro Val Thr Cys Cys Tyr Asn Val Val 
1               5                   10                  15      


Lys Gln Lys Ile His Val Arg Lys Leu Lys Ser Tyr Arg Arg Ile Thr 
            20                  25                  30          


Ser Ser Gln Cys Pro Arg Glu Ala Val Ile Phe Arg Thr Ile Leu Asp 
        35                  40                  45              


Lys Glu Ile Cys Ala Asp Pro Lys Glu Lys Trp Val Lys Asn Ser Ile 
    50                  55                  60                  


Asn His Leu Asp Lys Thr Ser Gln Thr Phe Ile Leu Glu Pro Ser Cys 
65                  70                  75                  80  


Leu Gly 
        


<210>  6
<211>  76
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide

<400>  6

Gly Pro Asp Ala Val Ser Thr Pro Val Thr Cys Cys Tyr Asn Val Val 
1               5                   10                  15      


Lys Gln Lys Ile His Val Arg Lys Leu Lys Ser Tyr Arg Arg Ile Thr 
            20                  25                  30          


Ser Ser Gln Cys Pro Arg Glu Ala Val Ile Phe Arg Thr Ile Leu Asp 
        35                  40                  45              


Lys Glu Ile Cys Ala Asp Pro Lys Glu Lys Trp Val Lys Asn Ser Ile 
    50                  55                  60                  


Asn His Leu Asp Lys Thr Ser Gln Thr Phe Ile Leu 
65                  70                  75      


<210>  7
<211>  76
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide

<400>  7

Gly Pro Asp Ala Val Ser Thr Pro Val Thr Cys Cys Tyr Asn Val Val 
1               5                   10                  15      


Lys Gln Lys Ile His Val Arg Lys Leu Lys Ser Tyr Arg Arg Ile Thr 
            20                  25                  30          


Ser Ser Gln Cys Pro Arg Glu Ala Val Ile Phe Arg Thr Ile Leu Asp 
        35                  40                  45              


Lys Glu Ile Cys Ala Asp Pro Lys Glu Lys Trp Val Lys Asn Ser Ile 
    50                  55                  60                  


Asn His Leu Asp Lys Thr Ser Gln Thr Phe Lys Leu 
65                  70                  75      


<210>  8
<211>  76
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu

<400>  8

Xaa Pro Asp Ala Ile Asn Ala Pro Val Thr Cys Cys Tyr Asn Phe Thr 
1               5                   10                  15      


Asn Arg Lys Ile Ser Val Gln Arg Leu Ala Ser Tyr Arg Arg Ile Thr 
            20                  25                  30          


Ser Ser Lys Cys Pro Lys Glu Ala Val Ile Phe Lys Thr Ile Val Ala 
        35                  40                  45              


Lys Glu Ile Cys Ala Asp Pro Lys Gln Lys Trp Val Gln Asp Ser Met 
    50                  55                  60                  


Asp His Leu Asp Lys Gln Thr Gln Thr Pro Lys Thr 
65                  70                  75      


<210>  9
<211>  76
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu

<220>
<221>  X
<222>  (75)..(75)
<223>  X is K(ivDde)

<400>  9

Xaa Pro Asp Ala Ile Asn Ala Pro Val Thr Cys Cys Tyr Asn Phe Thr 
1               5                   10                  15      


Asn Arg Lys Ile Ser Val Gln Arg Leu Ala Ser Tyr Arg Arg Ile Thr 
            20                  25                  30          


Ser Ser Lys Cys Pro Lys Glu Ala Val Ile Phe Lys Thr Ile Val Ala 
        35                  40                  45              


Lys Glu Ile Cys Ala Asp Pro Lys Gln Lys Trp Val Gln Asp Ser Met 
    50                  55                  60                  


Asp His Leu Asp Lys Gln Thr Gln Thr Pro Xaa Thr 
65                  70                  75      


<210>  10
<211>  76
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu

<220>
<221>  X
<222>  (75)..(75)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated, optionally via a spacer molecule such as PEG, e.g. 
       K(PEG-Biotin)

<400>  10

Xaa Pro Asp Ala Ile Asn Ala Pro Val Thr Cys Cys Tyr Asn Phe Thr 
1               5                   10                  15      


Asn Arg Lys Ile Ser Val Gln Arg Leu Ala Ser Tyr Arg Arg Ile Thr 
            20                  25                  30          


Ser Ser Lys Cys Pro Lys Glu Ala Val Ile Phe Lys Thr Ile Val Ala 
        35                  40                  45              


Lys Glu Ile Cys Ala Asp Pro Lys Gln Lys Trp Val Gln Asp Ser Met 
    50                  55                  60                  


Asp His Leu Asp Lys Gln Thr Gln Thr Pro Xaa Thr 
65                  70                  75      


<210>  11
<211>  76
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu

<400>  11

Xaa Pro Asp Ser Val Ser Ile Pro Ile Thr Cys Cys Phe Asn Val Ile 
1               5                   10                  15      


Asn Arg Lys Ile Pro Ile Gln Arg Leu Glu Ser Tyr Thr Arg Ile Thr 
            20                  25                  30          


Asn Ile Gln Cys Pro Lys Glu Ala Val Ile Phe Lys Thr Lys Arg Gly 
        35                  40                  45              


Lys Glu Val Cys Ala Asp Pro Lys Glu Arg Trp Val Arg Asp Ser Met 
    50                  55                  60                  


Lys His Leu Asp Gln Ile Phe Gln Asn Leu Lys Pro 
65                  70                  75      


<210>  12
<211>  76
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu

<220>
<221>  X
<222>  (75)..(75)
<223>  X is K(ivDde)

<400>  12

Xaa Pro Asp Ser Val Ser Ile Pro Ile Thr Cys Cys Phe Asn Val Ile 
1               5                   10                  15      


Asn Arg Lys Ile Pro Ile Gln Arg Leu Glu Ser Tyr Thr Arg Ile Thr 
            20                  25                  30          


Asn Ile Gln Cys Pro Lys Glu Ala Val Ile Phe Lys Thr Lys Arg Gly 
        35                  40                  45              


Lys Glu Val Cys Ala Asp Pro Lys Glu Arg Trp Val Arg Asp Ser Met 
    50                  55                  60                  


Lys His Leu Asp Gln Ile Phe Gln Asn Leu Xaa Pro 
65                  70                  75      


<210>  13
<211>  76
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu

<220>
<221>  X
<222>  (75)..(75)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated, optionally via a spacer molecule such as PEG, e.g. 
       K(PEG-Biotin)

<400>  13

Xaa Pro Asp Ser Val Ser Ile Pro Ile Thr Cys Cys Phe Asn Val Ile 
1               5                   10                  15      


Asn Arg Lys Ile Pro Ile Gln Arg Leu Glu Ser Tyr Thr Arg Ile Thr 
            20                  25                  30          


Asn Ile Gln Cys Pro Lys Glu Ala Val Ile Phe Lys Thr Lys Arg Gly 
        35                  40                  45              


Lys Glu Val Cys Ala Asp Pro Lys Glu Arg Trp Val Arg Asp Ser Met 
    50                  55                  60                  


Lys His Leu Asp Gln Ile Phe Gln Asn Leu Xaa Pro 
65                  70                  75      


<210>  14
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (73)..(73)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated, optionally via a spacer molecule such as PEG, e.g. 
       K(PEG-Biotin)

<400>  14

Gly Pro Ala Ser Val Pro Thr Thr Cys Cys Phe Asn Leu Ala Asn Arg 
1               5                   10                  15      


Lys Ile Pro Leu Gln Arg Leu Glu Ser Tyr Arg Arg Ile Thr Ser Gly 
            20                  25                  30          


Lys Cys Pro Gln Lys Ala Val Ile Phe Lys Thr Lys Leu Ala Lys Asp 
        35                  40                  45              


Ile Cys Ala Asp Pro Lys Lys Lys Trp Val Gln Asp Ser Met Lys Tyr 
    50                  55                  60                  


Leu Asp Gln Lys Ser Pro Thr Pro Xaa Pro 
65                  70                  


<210>  15
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (73)..(73)
<223>  X is K(ivDde)

<400>  15

Gly Pro Ala Ser Val Pro Thr Thr Cys Cys Phe Asn Leu Ala Asn Arg 
1               5                   10                  15      


Lys Ile Pro Leu Gln Arg Leu Glu Ser Tyr Arg Arg Ile Thr Ser Gly 
            20                  25                  30          


Lys Cys Pro Gln Lys Ala Val Ile Phe Lys Thr Lys Leu Ala Lys Asp 
        35                  40                  45              


Ile Cys Ala Asp Pro Lys Lys Lys Trp Val Gln Asp Ser Met Lys Tyr 
    50                  55                  60                  


Leu Asp Gln Lys Ser Pro Thr Pro Xaa Pro 
65                  70                  


<210>  16
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (73)..(73)
<223>  X is K(PEG-Biotin)

<400>  16

Gly Pro Ala Ser Val Pro Thr Thr Cys Cys Phe Asn Leu Ala Asn Arg 
1               5                   10                  15      


Lys Ile Pro Leu Gln Arg Leu Glu Ser Tyr Arg Arg Ile Thr Ser Gly 
            20                  25                  30          


Lys Cys Pro Gln Lys Ala Val Ile Phe Lys Thr Lys Leu Ala Lys Asp 
        35                  40                  45              


Ile Cys Ala Asp Pro Lys Lys Lys Trp Val Gln Asp Ser Met Lys Tyr 
    50                  55                  60                  


Leu Asp Gln Lys Ser Pro Thr Pro Xaa Pro 
65                  70                  


<210>  17
<211>  68
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide

<400>  17

Ser Pro Tyr Ser Ser Asp Thr Thr Pro Cys Cys Phe Ala Tyr Ile Ala 
1               5                   10                  15      


Arg Pro Leu Pro Arg Ala His Ile Lys Glu Tyr Phe Tyr Thr Ser Gly 
            20                  25                  30          


Lys Cys Ser Asn Pro Ala Val Val Phe Val Thr Arg Lys Asn Arg Gln 
        35                  40                  45              


Val Cys Ala Asn Pro Glu Lys Lys Trp Val Arg Glu Tyr Ile Asn Ser 
    50                  55                  60                  


Leu Glu Lys Ser 
65              


<210>  18
<211>  68
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (67)..(67)
<223>  X is K(ivDde)

<400>  18

Ser Pro Tyr Ser Ser Asp Thr Thr Pro Cys Cys Phe Ala Tyr Ile Ala 
1               5                   10                  15      


Arg Pro Leu Pro Arg Ala His Ile Lys Glu Tyr Phe Tyr Thr Ser Gly 
            20                  25                  30          


Lys Cys Ser Asn Pro Ala Val Val Phe Val Thr Arg Lys Asn Arg Gln 
        35                  40                  45              


Val Cys Ala Asn Pro Glu Lys Lys Trp Val Arg Glu Tyr Ile Asn Ser 
    50                  55                  60                  


Leu Glu Xaa Ser 
65              


<210>  19
<211>  68
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (67)..(67)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated, optionally via a spacer molecule such as PEG, e.g. 
       K(PEG-Biotin)

<400>  19

Ser Pro Tyr Ser Ser Asp Thr Thr Pro Cys Cys Phe Ala Tyr Ile Ala 
1               5                   10                  15      


Arg Pro Leu Pro Arg Ala His Ile Lys Glu Tyr Phe Tyr Thr Ser Gly 
            20                  25                  30          


Lys Cys Ser Asn Pro Ala Val Val Phe Val Thr Arg Lys Asn Arg Gln 
        35                  40                  45              


Val Cys Ala Asn Pro Glu Lys Lys Trp Val Arg Glu Tyr Ile Asn Ser 
    50                  55                  60                  


Leu Glu Xaa Ser 
65              


<210>  20
<211>  70
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide

<400>  20

Ala Ser Asn Phe Asp Cys Cys Leu Gly Tyr Thr Asp Arg Ile Leu His 
1               5                   10                  15      


Pro Lys Phe Ile Val Gly Phe Thr Arg Gln Leu Ala Asn Glu Gly Cys 
            20                  25                  30          


Asp Ile Asn Ala Ile Ile Phe His Thr Lys Lys Lys Leu Ser Val Cys 
        35                  40                  45              


Ala Asn Pro Lys Gln Thr Trp Val Lys Tyr Ile Val Arg Leu Leu Ser 
    50                  55                  60                  


Lys Lys Val Lys Asn Met 
65                  70  


<210>  21
<211>  70
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (68)..(68)
<223>  X is K(ivDde)

<400>  21

Ala Ser Asn Phe Asp Cys Cys Leu Gly Tyr Thr Asp Arg Ile Leu His 
1               5                   10                  15      


Pro Lys Phe Ile Val Gly Phe Thr Arg Gln Leu Ala Asn Glu Gly Cys 
            20                  25                  30          


Asp Ile Asn Ala Ile Ile Phe His Thr Lys Lys Lys Leu Ser Val Cys 
        35                  40                  45              


Ala Asn Pro Lys Gln Thr Trp Val Lys Tyr Ile Val Arg Leu Leu Ser 
    50                  55                  60                  


Lys Lys Val Xaa Asn Met 
65                  70  


<210>  22
<211>  70
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (68)..(68)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated, optionally via a spacer molecule such as PEG, e.g. 
       K(PEG-Biotin)

<400>  22

Ala Ser Asn Phe Asp Cys Cys Leu Gly Tyr Thr Asp Arg Ile Leu His 
1               5                   10                  15      


Pro Lys Phe Ile Val Gly Phe Thr Arg Gln Leu Ala Asn Glu Gly Cys 
            20                  25                  30          


Asp Ile Asn Ala Ile Ile Phe His Thr Lys Lys Lys Leu Ser Val Cys 
        35                  40                  45              


Ala Asn Pro Lys Gln Thr Trp Val Lys Tyr Ile Val Arg Leu Leu Ser 
    50                  55                  60                  


Lys Lys Val Xaa Asn Met 
65                  70  


<210>  23
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu or Gln

<220>
<221>  X
<222>  (64)..(64)
<223>  X = Norleucine

<400>  23

Xaa Gly Val Phe Glu Asp Cys Cys Leu Ala Tyr His Tyr Pro Ile Gly 
1               5                   10                  15      


Trp Ala Val Leu Arg Arg Ala Trp Thr Tyr Arg Ile Gln Glu Val Ser 
            20                  25                  30          


Gly Ser Cys Asn Leu Pro Ala Ala Ile Phe Tyr Leu Pro Lys Arg His 
        35                  40                  45              


Arg Lys Val Cys Gly Asn Pro Lys Ser Arg Glu Val Gln Arg Ala Xaa 
    50                  55                  60                  


Lys Leu Leu Asp Ala Arg Asn Lys Val Phe 
65                  70                  


<210>  24
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu or Gln

<220>
<221>  X
<222>  (64)..(64)
<223>  X = Norleucine

<220>
<221>  X
<222>  (72)..(72)
<223>  X is K(ivDde)

<400>  24

Xaa Gly Val Phe Glu Asp Cys Cys Leu Ala Tyr His Tyr Pro Ile Gly 
1               5                   10                  15      


Trp Ala Val Leu Arg Arg Ala Trp Thr Tyr Arg Ile Gln Glu Val Ser 
            20                  25                  30          


Gly Ser Cys Asn Leu Pro Ala Ala Ile Phe Tyr Leu Pro Lys Arg His 
        35                  40                  45              


Arg Lys Val Cys Gly Asn Pro Lys Ser Arg Glu Val Gln Arg Ala Xaa 
    50                  55                  60                  


Lys Leu Leu Asp Ala Arg Asn Xaa Val Phe 
65                  70                  


<210>  25
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu or Gln

<220>
<221>  X
<222>  (64)..(64)
<223>  X = Norleucine

<220>
<221>  X
<222>  (72)..(72)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated, optionally via a spacer molecule such as PEG, e.g. 
       K(PEG-Biotin)

<400>  25

Xaa Gly Val Phe Glu Asp Cys Cys Leu Ala Tyr His Tyr Pro Ile Gly 
1               5                   10                  15      


Trp Ala Val Leu Arg Arg Ala Trp Thr Tyr Arg Ile Gln Glu Val Ser 
            20                  25                  30          


Gly Ser Cys Asn Leu Pro Ala Ala Ile Phe Tyr Leu Pro Lys Arg His 
        35                  40                  45              


Arg Lys Val Cys Gly Asn Pro Lys Ser Arg Glu Val Gln Arg Ala Xaa 
    50                  55                  60                  


Lys Leu Leu Asp Ala Arg Asn Xaa Val Phe 
65                  70                  


<210>  26
<211>  73
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide

<400>  26

Phe Pro Met Phe Lys Arg Gly Arg Cys Leu Cys Ile Gly Pro Gly Val 
1               5                   10                  15      


Lys Ala Val Lys Val Ala Asp Ile Glu Lys Ala Ser Ile Met Tyr Pro 
            20                  25                  30          


Ser Asn Asn Cys Asp Lys Ile Glu Val Ile Ile Thr Leu Lys Glu Asn 
        35                  40                  45              


Lys Gly Gln Arg Cys Leu Asn Pro Lys Ser Lys Gln Ala Arg Leu Ile 
    50                  55                  60                  


Ile Lys Lys Val Glu Arg Lys Asn Phe 
65                  70              


<210>  27
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (74)..(74)
<223>  X is PEG-K(ivDde)

<400>  27

Phe Pro Met Phe Lys Arg Gly Arg Cys Leu Cys Ile Gly Pro Gly Val 
1               5                   10                  15      


Lys Ala Val Lys Val Ala Asp Ile Glu Lys Ala Ser Ile Met Tyr Pro 
            20                  25                  30          


Ser Asn Asn Cys Asp Lys Ile Glu Val Ile Ile Thr Leu Lys Glu Asn 
        35                  40                  45              


Lys Gly Gln Arg Cys Leu Asn Pro Lys Ser Lys Gln Ala Arg Leu Ile 
    50                  55                  60                  


Ile Lys Lys Val Glu Arg Lys Asn Phe Xaa 
65                  70                  


<210>  28
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (74)..(74)
<223>  X = residue that can be biotinylated, e.g. lysine, ornithine or 
       diaminopropionic acid and optionally is biotinylated, optionally 
       via a spacer molecule such as PEG, e.g. K(PEG-Biotin) and may be 
       attached via a spacer molecule, e.g.PEG-K(Biotin)

<400>  28

Phe Pro Met Phe Lys Arg Gly Arg Cys Leu Cys Ile Gly Pro Gly Val 
1               5                   10                  15      


Lys Ala Val Lys Val Ala Asp Ile Glu Lys Ala Ser Ile Met Tyr Pro 
            20                  25                  30          


Ser Asn Asn Cys Asp Lys Ile Glu Val Ile Ile Thr Leu Lys Glu Asn 
        35                  40                  45              


Lys Gly Gln Arg Cys Leu Asn Pro Lys Ser Lys Gln Ala Arg Leu Ile 
    50                  55                  60                  


Ile Lys Lys Val Glu Arg Lys Asn Phe Xaa 
65                  70                  


<210>  29
<211>  77
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide

<400>  29

Val Pro Leu Ser Arg Thr Val Arg Cys Thr Cys Ile Ser Ile Ser Asn 
1               5                   10                  15      


Gln Pro Val Asn Pro Arg Ser Leu Glu Lys Leu Glu Ile Ile Pro Ala 
            20                  25                  30          


Ser Gln Phe Cys Pro Arg Val Glu Ile Ile Ala Thr Met Lys Lys Lys 
        35                  40                  45              


Gly Glu Lys Arg Cys Leu Asn Pro Glu Ser Lys Ala Ile Lys Asn Leu 
    50                  55                  60                  


Leu Lys Ala Val Ser Lys Glu Arg Ser Lys Arg Ser Pro 
65                  70                  75          


<210>  30
<211>  78
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (77)..(77)
<223>  X is K(ivDde), optionally attached via a spacer such as PEG, e.g.
       -PEG-K(ivDde)

<220>
<221>  misc_feature
<222>  (78)..(78)
<223>  Xaa can be any naturally occurring amino acid

<400>  30

Val Pro Leu Ser Arg Thr Val Arg Cys Thr Cys Ile Ser Ile Ser Asn 
1               5                   10                  15      


Gln Pro Val Asn Pro Arg Ser Leu Glu Lys Leu Glu Ile Ile Pro Ala 
            20                  25                  30          


Ser Gln Phe Cys Pro Arg Val Glu Ile Ile Ala Thr Met Lys Lys Lys 
        35                  40                  45              


Gly Glu Lys Arg Cys Leu Asn Pro Glu Ser Lys Ala Ile Lys Asn Leu 
    50                  55                  60                  


Leu Lys Ala Val Ser Lys Glu Arg Ser Lys Arg Ser Pro Xaa 
65                  70                  75              


<210>  31
<211>  78
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (77)..(77)
<223>  X = residue that can be biotinylated, e.g. lysine, ornithine or 
       diaminopropionic acid and optionally is biotinylated, optionally 
       via a spacer molecule such as PEG, e.g. K(PEG-Biotin) and may be 
       attached via a spacer molecule, e.g.PEG-K(Biotin)

<220>
<221>  misc_feature
<222>  (78)..(78)
<223>  Xaa can be any naturally occurring amino acid

<400>  31

Val Pro Leu Ser Arg Thr Val Arg Cys Thr Cys Ile Ser Ile Ser Asn 
1               5                   10                  15      


Gln Pro Val Asn Pro Arg Ser Leu Glu Lys Leu Glu Ile Ile Pro Ala 
            20                  25                  30          


Ser Gln Phe Cys Pro Arg Val Glu Ile Ile Ala Thr Met Lys Lys Lys 
        35                  40                  45              


Gly Glu Lys Arg Cys Leu Asn Pro Glu Ser Lys Ala Ile Lys Asn Leu 
    50                  55                  60                  


Leu Lys Ala Val Ser Lys Glu Arg Ser Lys Arg Ser Pro Xaa 
65                  70                  75              


